Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lines Skin”

759 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 759 results

Large-scale testing (Phase 3)Looking for participantsNCT06767527
What this trial is testing

AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Akeso 416
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05979220
What this trial is testing

Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy

Who this might be right for
Breast Cancer
Shuangyue Liu 178
Large-scale testing (Phase 3)Active Not RecruitingNCT04784715
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Who this might be right for
Breast Cancer; HER2-positive; Metastatic
AstraZeneca 1,157
Not applicableStudy completedNCT05097157
What this trial is testing

Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions

Who this might be right for
WrinkleFine LinesCrepey Skin+5 more
Cynosure, Inc. 79
Not applicableStudy completedNCT00032201
What this trial is testing

Cell Lines From High-Risk Breast Tissue

Who this might be right for
Healthy
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT03438279
What this trial is testing

Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 600
Large-scale testing (Phase 3)UnknownNCT02383030
What this trial is testing

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 156
Large-scale testing (Phase 3)Active Not RecruitingNCT05374512
What this trial is testing

Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

Who this might be right for
Breast Cancer
AstraZeneca 644
Not applicableStudy completedNCT06657365
What this trial is testing

Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles

Who this might be right for
Facial WrinklesAnti-AgingWrinkles and Rhytides+2 more
CLASSYS Inc. 284
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Large-scale testing (Phase 3)Study completedNCT02101333
What this trial is testing

Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis

Who this might be right for
TAKAYASU ARTERITIS
Assistance Publique - Hôpitaux de Paris 18
Testing effectiveness (Phase 2)UnknownNCT06133192
What this trial is testing

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD

Who this might be right for
Graft Vs Host Disease
Central Hospital, Nancy, France 42
Testing effectiveness (Phase 2)Study completedNCT00356811
What this trial is testing

Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944434
What this trial is testing

FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer

Who this might be right for
Breast Cancer
Fondazione Sandro Pitigliani 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT00585507
What this trial is testing

Efficacy and Safety of 500mg of Fulvestrant

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 40
Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Not applicableStudy completedNCT04969380
What this trial is testing

SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Who this might be right for
Skin Laxity
Sofwave Medical LTD 20
Not applicableEnded earlyNCT00764959
What this trial is testing

Retrospective Study of the Linear™ Hip

Who this might be right for
OsteoarthritisRheumatoid ArthritisFemoral Fracture+2 more
Encore Medical, L.P. 200
Testing effectiveness (Phase 2)Study completedNCT00601159
What this trial is testing

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Who this might be right for
Metastatic Breast Cancer
Fudan University 70
Large-scale testing (Phase 3)Looking for participantsNCT06081959
What this trial is testing

Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Load More Results